Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young

Nicole Hellenthal1, Anna Gaertner-Rommel2, Bärbel Klauke2

  • 1Universitätsklinikum Hamburg Eppendorf, Institut für Rechtsmedizin, Butenfeld 34, D-22529 Hamburg, Germany.

Insights

Genetic testing identified underlying heart conditions in 80% of young sudden unexplained death victims. This molecular autopsy approach aids in preventing further family deaths.

Area of Science:

  • Forensic pathology
  • Cardiovascular genetics
  • Molecular diagnostics

Background:

  • Sudden cardiac death (SCD) in younger individuals (<35 years) often stems from genetic cardiomyopathies and arrhythmogenic disorders.
  • Identifying the genetic cause of death is crucial for preventing further fatalities within affected families.

Observation:

  • A study examined 10 forensic cases of sudden unexplained death (SUD) in victims aged 19-40.
  • Next-generation sequencing of 174 candidate genes was performed on DNA from these victims.

Findings:

  • Genetic disposition for heart disease was found in 80% (8/10) of SUD cases.
  • Pathogenic mutations were identified in 3 cases, and variants of uncertain significance in 5 cases.
  • Family screening revealed two additional mutation carriers.

Implications:

  • Molecular genetics significantly enhances post-mortem diagnosis of fatal genetic heart diseases in SUD victims.
  • Integrating molecular genetics into routine forensic and pathological practice is recommended for improved diagnostic yield and family-specific prevention strategies.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
545
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
959
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
445
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
670
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
654